[Calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis. A review].

Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete
M A RadtkeM Augustin

Abstract

Scalp psoriasis has a significant psychosocial impact on individuals affecting their quality of life. It occurs in 50-80% of patients with psoriasis and may be the only affected area of the body. Current topical therapies for scalp psoriasis are difficult or unpleasant to apply, resulting in decreased adherence and efficacy. A combination of calcipotriol and betamethasone dipropionate in a gel formulation has been developed and approved in Germany for the treatment of scalp psoriasis. Multiple randomized controlled clinical trials have confirmed the efficacy and safety of the new formulation. After two weeks, 60% of patients showed significant improvement; this climbed to 70%, after eight weeks. It may be safely used for up to 52 weeks. No cases of atrophy, striae, or steroid purpura were noted in two 52-week studies. Although scalp psoriasis can often be adequately treated with topical therapy, there is a need for treatment recommendations and algorithms for severe forms and for patients with extended body involvement, taking the combination of systemic and topical treatment and the presence of comorbidities into account.

References

Aug 1, 1991·The Journal of Investigative Dermatology·P MildeE W Rauterberg
Jan 1, 1974·Dermatologica·E M Farber, M L Nall
Jan 1, 1996·Skin Pharmacology : the Official Journal of the Skin Pharmacology Society·C J van der VleutenP C van de Kerkhof
Jan 1, 1997·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·G MichelT Ruzicka
Jul 1, 1997·Journal of the American Academy of Dermatology·M LebwohlB Patel
Aug 7, 1998·Dermatology : International Journal for Clinical and Investigative Dermatology·P C van de KerkhofM V Kuipers
Jan 5, 1999·Dermatology : International Journal for Clinical and Investigative Dermatology·P C van de KerkhofM V Kuipers
Jan 20, 1999·The British Journal of Dermatology·K KragballeP C Van De Kerkhof
Apr 8, 2000·Skin Pharmacology and Applied Skin Physiology·K LangeM Schäfer-Korting
Jul 15, 2000·Dermatology : International Journal for Clinical and Investigative Dermatology·P C van de KerkhofM V Kuipers
Oct 29, 2000·Dermatology : International Journal for Clinical and Investigative Dermatology·P E HutchinsonJ White
Oct 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A BoonstraA O'Garra
Apr 16, 2002·The British Journal of Dermatology·J MasonM J Cork
May 31, 2002·Dermatology : International Journal for Clinical and Investigative Dermatology·P C M Van de KerkhofD M Tillman
Apr 12, 2003·American Journal of Clinical Dermatology·Steven R Feldman, Tamara S Housman
May 15, 2003·The Journal of Dermatological Treatment·J M CamarasaL Dubertret
Aug 16, 2003·Dermatology : International Journal for Clinical and Investigative Dermatology·J Traulsen, B J Hughes-Formella
Feb 18, 2004·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·T Ruzicka, C Trompke
Aug 12, 2004·International Journal of Dermatology·Jette Traulsen
Sep 29, 2004·Dermatologic Clinics·David S Aaronson, Mark Lebwohl
Oct 20, 2004·The British Journal of Dermatology·C L CarrollR Balkrishnan
Oct 3, 2006·Journal of the American Academy of Dermatology·Katherine K BrownAlexa B Kimball
May 15, 2007·Journal of the American Academy of Dermatology·Steven R FeldmanRajesh Balkrishnan
Jul 11, 2007·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander NastUNKNOWN Berufsverband Deutscher Dermatologen (BVDD)
May 9, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·Colin BuckleyMette Milsgaard
Sep 13, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·T A LugerN H Shear
Sep 20, 2008·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Matthias AugustinMarc Radtke
Jan 13, 2009·ChemMedChem·Leo LeungBruno Linclau
Jan 20, 2009·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·W-H BoehnckeS Boehncke
Feb 27, 2009·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Matthias AugustinUlrich Moehling
Jul 21, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·Jp OrtonneR M Trüeb

❮ Previous
Next ❯

Citations

Mar 19, 2019·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Andreas KörberUNKNOWN PsoNet Förderverein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.